Search Results - "Fjøsne, Hans E"

Support vector machine for breast cancer classification using diffusion‐weighted MRI histogram features: Preliminary study by Vidić, Igor, Egnell, Liv, Jerome, Neil P., Teruel, Jose R., Sjøbakk, Torill E., Østlie, Agnes, Fjøsne, Hans E., Bathen, Tone F., Goa, Pål Erik

“…Background Diffusion‐weighted MRI (DWI) is currently one of the fastest developing MRI‐based techniques in oncology. Histogram properties from model fitting of…”
Get full text

Inhomogeneous static magnetic field-induced distortion correction applied to diffusion weighted MRI of the breast at 3T by Teruel, Jose R., Fjøsne, Hans E., Østlie, Agnes, Holland, Dominic, Dale, Anders M., Bathen, Tone F., Goa, Pål E.

“…Purpose To evaluate the performance of an advanced method for correction of inhomogeneous static magnetic field induced distortion in echo‐planar imaging…”
Get full text

A Simplified Approach to Measure the Effect of the Microvasculature in Diffusion-weighted MR Imaging Applied to Breast Tumors: Preliminary Results by Teruel, Jose R, Goa, Pål E, Sjøbakk, Torill E, Østlie, Agnes, Fjøsne, Hans E, Bathen, Tone F

“…Purpose To evaluate the relative change of the apparent diffusion coefficient (ADC) at low- and medium-b-value regimens as a surrogate marker of…”
Get full text

Quantification of metabolites in breast cancer patients with different clinical prognosis using HR MAS MR spectroscopy by Sitter, Beathe, Bathen, Tone F., Singstad, Trond E., Fjøsne, Hans E., Lundgren, Steinar, Halgunset, Jostein, Gribbestad, Ingrid S.

“…Absolute quantitative measures of breast cancer tissue metabolites can increase our understanding of biological processes. Electronic REference To access In…”
Get full text

Diffusion weighted imaging for the differentiation of breast tumors: From apparent diffusion coefficient to high order diffusion tensor imaging by Teruel, Jose R., Goa, Pål E., Sjøbakk, Torill E., Østlie, Agnes, Fjøsne, Hans E., Bathen, Tone F.

“…Background To compare “standard” diffusion weighted imaging, and diffusion tensor imaging (DTI) of 2nd and 4th‐order for the differentiation of malignant and…”
Get full text

Feasibility of MR metabolomics for immediate analysis of resection margins during breast cancer surgery by Bathen, Tone F, Geurts, Brigitte, Sitter, Beathe, Fjøsne, Hans E, Lundgren, Steinar, Buydens, Lutgarde M, Gribbestad, Ingrid S, Postma, Geert, Giskeødegård, Guro F

“…In this study, the feasibility of high resolution magic angle spinning (HR MAS) magnetic resonance spectroscopy (MRS) of small tissue biopsies to distinguish…”
Get full text

Lactate and glycine-potential MR biomarkers of prognosis in estrogen receptor-positive breast cancers by Giskeødegård, Guro F., Lundgren, Steinar, Sitter, Beathe, Fjøsne, Hans E., Postma, Geert, Buydens, Lutgarde M. C., Gribbestad, Ingrid S., Bathen, Tone F.

“…Breast cancer is a heterogeneous disease with a variable prognosis. Clinical factors provide some information about the prognosis of patients with breast…”
Get full text

Understanding diffusion‐weighted MRI analysis: Repeatability and performance of diffusion models in a benign breast lesion cohort by Jerome, Neil Peter, Vidić, Igor, Egnell, Liv, Sjøbakk, Torill E., Østlie, Agnes, Fjøsne, Hans E., Goa, Pål Erik, Bathen, Tone F.

“…Diffusion‐weighted MRI (DWI) is an important tool for oncology research, with great clinical potential for the classification and monitoring of breast lesions…”
Get full text

Metabolite and lipoprotein responses and prediction of weight gain during breast cancer treatment by Madssen, Torfinn S., Thune, Inger, Flote, Vidar G., Lundgren, Steinar, Bertheussen, Gro F., Frydenberg, Hanne, Wist, Erik, Schlichting, Ellen, Schäfer, Hartmut, Fjøsne, Hans E., Vettukattil, Riyas, Lømo, Jon, Bathen, Tone F., Giskeødegård, Guro F.

“…Background Breast cancer treatment has metabolic side effects, potentially affecting risk of cardiovascular disease (CVD) and recurrence. We aimed to compare…”
Get full text

Multivariate Modeling and Prediction of Breast Cancer Prognostic Factors Using MR Metabolomics by Giskeødegård, Guro F, Grinde, Maria T, Sitter, Beathe, Axelson, David E, Lundgren, Steinar, Fjøsne, Hans E, Dahl, Steinar, Gribbestad, Ingrid S, Bathen, Tone F

“…Axillary lymph node status together with estrogen and progesterone receptor status are important prognostic factors in breast cancer. In this study, the…”
Get full text

Interactions between the tumor and the blood systemic response of breast cancer patients by Dumeaux, Vanessa, Fjukstad, Bjørn, Fjosne, Hans E, Frantzen, Jan-Ole, Holmen, Marit Muri, Rodegerdts, Enno, Schlichting, Ellen, Børresen-Dale, Anne-Lise, Bongo, Lars Ailo, Lund, Eiliv, Hallett, Michael

“…Although systemic immunity is critical to the process of tumor rejection, cancer research has largely focused on immune cells in the tumor microenvironment. To…”
Get full text

Predictive and prognostic impact of TP53 mutations and MDM2 promoter genotype in primary breast cancer patients treated with epirubicin or paclitaxel by Chrisanthar, Ranjan, Knappskog, Stian, Løkkevik, Erik, Anker, Gun, Ostenstad, Bjørn, Lundgren, Steinar, Risberg, Terje, Mjaaland, Ingvil, Skjønsberg, Gudbrand, Aas, Turid, Schlichting, Ellen, Fjösne, Hans E, Nysted, Arne, Lillehaug, Johan Richard, Lønning, Per Eystein

“…TP53 mutations have been associated with resistance to anthracyclines but not to taxanes in breast cancer patients. The MDM2 promoter single nucleotide…”
Get full text

Late onset metastases to the thyroid gland from renal carcinoma by Villumsen, Anne Lise, Mevik, Kjersti, Fjøsne, Hans E, Brekke, Marianne B, Haugen, Olav A

“…Metastases from renal cell carcinoma to the thyroid gland are uncommon and the clinical course often prolonged. We wished to determine the incidence of such…”
Get full text

Malignant melanoma--diagnosis, treatment and follow-up in Norway by Geisler, Jürgen, Bachmann, Ingeborg M, Nyakas, Marta, Helsing, Per, Fjøsne, Hans E, Mæhle, Lovise Olaug, Aamdal, Steinar, Eide, Nils A, Svendsen, Henrik L, Straume, Oddbjørn, Robsahm, Trude E, Jacobsen, Kari D, Akslen, Lars A

“…The incidence of malignant melanoma in Norway is among the highest in the world and rising, with approximately 1 500 persons receiving the diagnosis annually…”
Get full text

Hospital volume and prognosis among Norwegian breast cancer patients enrolled in adjuvant trials by Fjösne, Hans E, Søreide, Jon Arne, Kåresen, Rolf, Lønning, Per Eystein, Jacobsen, Anne-Birgitte, Lundgren, Steinar

“…Several studies have reported an association between breast cancer unit volume and prognosis. We hypothesize that this may be due to inappropriate coping with…”
Get more information

Increased Risk of Recurrence After Hormone Replacement Therapy in Breast Cancer Survivors by Holmberg, Lars, Iversen, Ole-Erik, Rudenstam, Carl Magnus, Hammar, Mats, Kumpulainen, Eero, Jaskiewicz, Janusz, Jassem, Jacek, Dobaczewska, Daria, Fjosne, Hans E., Peralta, Octavio, Arriagada, Rodrigo, Holmqvist, Marit, Maenpa, Johanna

“…Background Hormone replacement therapy (HT) is known to increase the risk of breast cancer in healthy women, but its effect on breast cancer risk in breast…”
Get full text

Peripheral blood cells inform on the presence of breast cancer: A population‐based case–control study by Dumeaux, Vanessa, Ursini‐Siegel, Josie, Flatberg, Arnar, Fjosne, Hans E., Frantzen, Jan‐Ole, Holmen, Marit Muri, Rodegerdts, Enno, Schlichting, Ellen, Lund, Eiliv

“…Tumor–host interactions extend beyond the local microenvironment and cancer development largely depends on the ability of malignant cells to hijack and exploit…”
Get full text

Comparison of HR MAS MR spectroscopic profiles of breast cancer tissue with clinical parameters by Sitter, Beathe, Lundgren, Steinar, Bathen, Tone F., Halgunset, Jostein, Fjosne, Hans E., Gribbestad, Ingrid S.

“…Breast cancer is the most frequent form of cancer in women and improved diagnostic methods are desirable. Malignant cells have altered metabolism and metabolic…”
Get full text

MR-determined metabolic phenotype of breast cancer in prediction of lymphatic spread, grade, and hormone status by BATHEN, Tone F, JENSEN, Line R, SITTER, Beathe, FJÖSNE, Hans E, HALGUNSET, Jostein, AXELSON, David E, GRIBBESTAD, Ingrid S, LUNDGREN, Steinar

“…The purpose of the study was to evaluate the use of metabolic phenotype, described by high-resolution magic angle spinning magnetic resonance spectroscopy (HR…”
Get full text

Senmetastaser til glandula thyreoidea fra nyrekarsinom by Villumsen, Anne Lise, Mevik, Kjersti, Fjøsne, Hans E, Brekke, Marianne B, Haugen, Olav A

Get full text